SUMMARY
TYZINE
(tetrahydrozoline hydrochloride)
NASAL SOLUTION
Tyzine® Nasal Solution contains tetrahydrozoline hydrochloride, 2-(1,2,3,4-Tetrahydro-1, naphthyl)-2-imidazoline monohydrochloride, as a nasal decongestant.
Tyzine® Nasal Solution is indicated for decongestion of nasal and nasopharyngeal mucosa.
|
NEWS HIGHLIGHTS
Published Studies Related to Tyzine Pediatric (Tetrahydrozoline Nasal)
Prolonged cardiovascular effects after unintentional ingestion of tetrahydrozoline. [2008.02]
Tetrahydrozoline is an imidazoline derivative with alpha receptor agonist activity widely available in over-the-counter topical ocular and nasal formulations... We report a case of unintentional tetrahydrozoline ingestion with cardiovascular effects persisting for 36 hours.
Pediatric Visine (tetrahydrozoline) ingestion: case report and review of imidazoline toxicity. [2003.08]
Visine, an over-the-counter, tetrahydrozoline topical ophthalmic decongestant, possesses central and peripheral alpha2-adrenergic properties. We present a case of accidental pediatric oral exposure with resultant neurological and cardiovascular complications... Over-the-counter medications with potent pharmacological properties should be stored in areas out of the reach of children, and manufacturers should package these products in childproof containers.
[The usage of nasal drops Tyzine in otorhinolaryngology] [1997]
In this research the authors presented their experiences in the treatment of non-complicated and complicated acute mucous membranous rhinitis with application of shrinking nasal drops Tyzine as a locally affective remedy assisting the therapy. The aim of this research was the estimation of the efficiency of Tyzine drops with mucous membranous rhinitis, their effect on the efficiency of the ciliary transport and stating the probable side effects occurring after their application...
Clinical Trials Related to Tyzine Pediatric (Tetrahydrozoline Nasal)
Study of Efficacy of Levofloxacin 0.5% Ophthalmic Solution Administered Three Times a Day for Bacterial Conjunctivitis [Completed]
The aim of the study is to evaluate the clinical and microbiological efficacies of three
times daily administration of levofloxacin 0,5% eye drops as compared to the more frequent
dosing (up to 8 times a day during the first 2 days and up to 4 times a day during the next
3 days) in patients with bacterial conjunctivitis.
Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel [Recruiting]
Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo [Active, not recruiting]
To evaluate the safety and efficacy of Nepafenac 1 mg/ml Eye Drops, Suspension, compared to
Placebo and Ketorolac Trometamol 5 mg/ml Eye Drops, Solution for the prevention and treatment
of ocular inflammation and ocular pain after cataract extraction with IOL implantation
Comparison of Autologous Serum and Umbilical Cord Serum Eyedrops for Dry Eye Syndrome [Completed]
To compare the therapeutic effect between autologous serum and umbilical cord serum eyedrops
in the treatment of severe dry eye syndrome.
Acute Comfort and Blur of Systane and Optive [Completed]
To evaluate drop comfort, acceptability, preference and blur profile between two marketed
artificial tears in both dry eye and non-dry eye patient population.
|
